APA (7th ed.) Citation

J, D., X, S., MA, R., C, E., A, C., CH, C., . . . N, V. (2023). Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus (RSV) Vaccine in Healthy RSV-Seropositive Children 12-23 Months of Age. The Journal of infectious diseases, 227(11), 1293. https://doi.org/10.1093/infdis/jiac481

Chicago Style (17th ed.) Citation

J, Díez-Domingo, et al. "Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus (RSV) Vaccine in Healthy RSV-Seropositive Children 12-23 Months of Age." The Journal of Infectious Diseases 227, no. 11 (2023): 1293. https://doi.org/10.1093/infdis/jiac481.

MLA (9th ed.) Citation

J, Díez-Domingo, et al. "Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus (RSV) Vaccine in Healthy RSV-Seropositive Children 12-23 Months of Age." The Journal of Infectious Diseases, vol. 227, no. 11, 2023, p. 1293, https://doi.org/10.1093/infdis/jiac481.